- Home
- WOW vs SAGE Comparison
WOW vs SAGE Comparison
Compare WOW & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- SAGE
- Stock Information
- Founded
- WOW 2001
- SAGE 2010
- Country
- WOW United States
- SAGE United States
- Employees
- WOW N/A
- SAGE N/A
- Industry
- WOW Cable & Other Pay Television Services
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- SAGE Health Care
- Exchange
- WOW Nasdaq
- SAGE Nasdaq
- Market Cap
- WOW 375.2M
- SAGE 413.9M
- IPO Year
- WOW 2017
- SAGE 2014
- Fundamental
- Price
- WOW $4.21
- SAGE $6.46
- Analyst Decision
- WOW Buy
- SAGE Hold
- Analyst Count
- WOW 2
- SAGE 19
- Target Price
- WOW $6.50
- SAGE $9.88
- AVG Volume (30 Days)
- WOW 271.6K
- SAGE 815.0K
- Earning Date
- WOW 05-06-2025
- SAGE 04-29-2025
- Dividend Yield
- WOW N/A
- SAGE N/A
- EPS Growth
- WOW N/A
- SAGE N/A
- EPS
- WOW N/A
- SAGE N/A
- Revenue
- WOW $619,400,000.00
- SAGE $47,404,000.00
- Revenue This Year
- WOW N/A
- SAGE $103.73
- Revenue Next Year
- WOW N/A
- SAGE $41.15
- P/E Ratio
- WOW N/A
- SAGE N/A
- Revenue Growth
- WOW N/A
- SAGE N/A
- 52 Week Low
- WOW $4.03
- SAGE $4.62
- 52 Week High
- WOW $5.80
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- WOW 43.68
- SAGE 38.73
- Support Level
- WOW $4.17
- SAGE $6.36
- Resistance Level
- WOW $4.36
- SAGE $6.78
- Average True Range (ATR)
- WOW 0.14
- SAGE 0.24
- MACD
- WOW -0.00
- SAGE -0.01
- Stochastic Oscillator
- WOW 29.63
- SAGE 12.22
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.